Diabetes Care Devices Market Size By Product (Blood Glucose Monitoring Devices {Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets}, Insulin Delivery Devices {Insulin Pumps [Tubed Pumps, Tubeless Pumps], Pen [Reusable, Disposable], Pen Needles [Standard, Safety], Syringes}), By End-Use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers, Home Care) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Published Date: Apr 2019 | Report ID: GMI3250 | Authors: Sumant Ugalmugle, Rupali Swain
Industry Trends
Diabetes Care Devices Market size valued at around USD 28 billion in 2018 and is expected to grow at 5.9% CAGR between 2019 and 2025. Increasing efforts by the government of various countries such as the U.S., Australia, Canada to incentivize and support diabetes care will positively influence the market revenue.
Get more details on this report - Request Free Sample PDF
Growing prevalence of diabetes across the world will significantly contribute to the global market demand. As per the International Diabetes Federation, about 425 million adults aged between 20 to 79 years of age were living with diabetes in 2017 and the number is estimated to escalate to 629 million by 2045. Rising prevalence and incidence of diabetes will accelerate the adoption of glucose monitoring as well as insulin delivery devices for better care and management of the disease, thus highly impacting the market growth trends.
Availability of reimbursement policies and insurance will boost the diabetes care devices market share. Reimbursements and insurance policies support the adoption and usage of diabetes care devices by diabetic patients. However, limited reimbursement for some diabetes care devices such as continuous glucose monitors and insulin pumps in few countries may restrain the industry growth.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2018 | Market Size in 2018: | 27.9 Billion (USD) |
| Historical Data for: | 2014 to 2018 | Forecast Period: | 2019 to 2025 |
| Forecast Period 2019 to 2025 CAGR: | 5.9% | 2025 Value Projection: | 41.5 Billion (USD) |
| Pages: | 260 | Tables, Charts & Figures: | 367 |
| Geographies covered (24): | U.S., Canada, Germany, France, UK, The Netherlands, Sweden, Belgium, Denmark, Finland, Norway, Lithuania, Latvia, Estonia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia | ||
| Segments covered: | Products, End-Use and Region | ||
| Companies covered (21): | Abbott Laboratories, Arkray, Inc., B. Braun Melsungen AG, Bayer Corporation, Dexcom Inc., F. Hoffmann-La Roche Ag, Johnson & Johnson (LifeScan, Inc.), Medtronic PLC, Sinocare, Inc., Nova Biomedical, Inc., Becton Dickinson and Company, Sanofi, Eli Lilly and Company, Insulet Corporation, Novo Nordisk, Wockhardt Limited, Ypsomed Holding AG, Companion Medical, Bespak (Consort Medical subsidiary), Valeritas Holdings Inc., West Pharmaceutical Services, Inc. | ||
| Growth Drivers: |
|
||
| Pitfalls & Challenges: |
|
||
Get more details on this report - Request Free Sample PDF
Market, By Product
Get more details on this report - Request Free Sample PDF
Blood glucose monitoring devices revenue exceeded USD 16.9 billion in 2018. Growing acceptance of blood glucose monitoring devices for diabetes care will largely impact adoption of such devices. Also, increasing number of admissions in healthcare facilities will result into greater adoption of blood glucose monitoring devices to prevent complications related to high blood sugar levels. With increasing incidence of diabetes, the need to monitor blood glucose continuously as well as the demand for self-monitoring of blood glucose will spur over the coming years.
Insulin delivery devices product segment is estimated to witness over 6.1% growth rate during the forecast timeframe. Insulin delivery devices are witnessing various technological advancements for better and efficient delivery of insulin. Novel insulin delivery devices include wearable drug delivery devices. Adoption for such devices will thus increase due to improved drug delivery and glucose control. Moreover, the demand for insulin pens among other insulin delivery devices is predicted to grow at a rapid pace owing to easy application, greater accuracy, and high convenience.
Market, By End-use
Get more details on this report - Request Free Sample PDF
Hospitals end-use segment accounted for the largest diabetes care devices market share of 45% in 2018. Growing hospitalization increases the need to accurately measure and control blood glucose, thereby avoiding morbidity, complications, and mortality. Growing chronic disease prevalence, especially diabetes, will increase the demand for diabetes care devices in hospitals. In addition, availability of portable and advanced devices for diabetes care in hospitals will impact the segment share.
Home care diabetes end-use segment is predicted to expand at 6.4% CAGR through 2025. There is an increasing adoption of blood sugar monitoring and insulin delivery devices in home care settings. High convenience, remote monitoring, portability along with considerable precision are the major factors for robust segment growth. Self-monitoring of blood sugar and control of blood glucose at home facilitates enhanced care and maintenance of diabetes with greater affordability.
Market, By Region
U.S. diabetes care devices market dominated around 91% revenue share in 2018 and is poised to exceed USD 14.5 billion by 2025 owing to rising population suffering from diabetes as well as increasing expenditure on diabetes care per person. Moreover, technological advancements coupled with approval of new products for diabetes monitoring and control in the country will propel the United States market expansion.
Germany market value was over USD 2.2 billion in 2018. High prevalence of diabetes is witnessed in Germany due to increasing adoption of sedentary lifestyle, unhealthy eating habits and growing obesity prevalence. Also, the German healthcare system provides reimbursement and insurance for majority of diabetes care devices that should boost the customer adoption rate for the products in the country. Additionally, high adoption of insulin delivery devices and increasing per capita spending on diabetes will spur the German industry revenue.
Competitive Market Share
Major organizations operating in the industry include Abbott Laboratories, Johnson & Johnson (LifeScan, Inc.), Medtronic plc, Becton Dickinson and Company, and Eli Lilly & Company. Firms are adopting new product development and strategic partnerships to earn higher profits in the market.
The diabetes care devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
Market, by Product
- Blood glucose monitoring devices
- Self-monitoring blood glucose meters
- Continuous glucose monitors
- Testing strips
- Lancets
- Insulin delivery devices
- Insulin pumps
- Tubed pumps
- Tubeless pumps
- Pens
- Reusable pens
- Disposable pens
- Pen needles
- Standard pen needles
- Safety pen needles
- Syringes
- Others
- Insulin pumps
Market, by End-use
- Hospitals
- Ambulatory surgery centers
- Diagnostic centers
- Home care
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- The Netherlands
- Sweden
- Belgium
- Denmark
- Finland
- Norway
- Lithuania
- Latvia
- Estonia
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Others
- Middle East & Africa
- South Africa
- Saudi Arabia
- Others
Frequently Asked Questions (FAQ) :
Buy Now
Need a Discount? Get in touch with us for special pricing
Request DiscountConnect with our sales team
- Phone: 1-302-846-7766
- Toll Free: 1-888-689-0688
- Email: sales@gminsights.com
- Chat With Us: Click here to start
Premium Report Details
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Customer Service
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.
GMIPulse, our report store
We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.